Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.

Despite recent advances in the treatment of hepatitis C, the quest for pan-genotype, effective, and well-tolerated inhibitors continues. To facilitate these efforts, it is desirable to have in vitro replication systems for all major HCV genotypes. However, cell culture replication systems exist for...

Full description

Bibliographic Details
Main Authors: Saeed, M, Scheel, T, Gottwein, J, Marukian, S, Dustin, L, Bukh, J, Rice, C
Format: Journal article
Language:English
Published: 2012
_version_ 1797095901741711360
author Saeed, M
Scheel, T
Gottwein, J
Marukian, S
Dustin, L
Bukh, J
Rice, C
author_facet Saeed, M
Scheel, T
Gottwein, J
Marukian, S
Dustin, L
Bukh, J
Rice, C
author_sort Saeed, M
collection OXFORD
description Despite recent advances in the treatment of hepatitis C, the quest for pan-genotype, effective, and well-tolerated inhibitors continues. To facilitate these efforts, it is desirable to have in vitro replication systems for all major HCV genotypes. However, cell culture replication systems exist for only genotypes 1a, 1b, and 2a. In this study, we generated G418-selectable subgenomic replicons for prototype strains of genotypes 3a (S52) and 4a (ED43). Production of G418-resistant colonies by S52 and ED43 in Huh-7.5 cells required the amino acid substitutions S2210I and R2882G, respectively, cell culture adaptive mutations originally reported for genotype 1b replicons. RNA replication was confirmed by quantitative reverse transcription-PCR and detection of viral protein. Sequencing of multiple independent replicon clones revealed the presence of additional nonsynonymous mutations. Interestingly, all potentially adaptive mutations mapped to the NS3 protein. These mutations, when introduced back into original constructs, substantially increased colony formation efficiency. To make these replicons useful for high-throughput screening and evaluation of antiviral compounds, they were modified to express a chimeric fusion protein of firefly luciferase and neomycin phosphotransferase to yield stable replicon-expressing cells. Using these constructs, the inhibitory effects of beta interferon (IFN-β), an NS3 protease inhibitor, and an NS5B nucleoside polymerase inhibitor were readily detected by monitoring luciferase activity. In conclusion, we have established functional replicons for HCV genotypes 3a and 4a, important new additions to the armamentarium required to develop inhibitors with a pan-genotype activity.
first_indexed 2024-03-07T04:34:34Z
format Journal article
id oxford-uuid:cf801ebe-c6df-461d-8f08-d0c06b52d505
institution University of Oxford
language English
last_indexed 2024-03-07T04:34:34Z
publishDate 2012
record_format dspace
spelling oxford-uuid:cf801ebe-c6df-461d-8f08-d0c06b52d5052022-03-27T07:42:51ZEfficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cf801ebe-c6df-461d-8f08-d0c06b52d505EnglishSymplectic Elements at Oxford2012Saeed, MScheel, TGottwein, JMarukian, SDustin, LBukh, JRice, CDespite recent advances in the treatment of hepatitis C, the quest for pan-genotype, effective, and well-tolerated inhibitors continues. To facilitate these efforts, it is desirable to have in vitro replication systems for all major HCV genotypes. However, cell culture replication systems exist for only genotypes 1a, 1b, and 2a. In this study, we generated G418-selectable subgenomic replicons for prototype strains of genotypes 3a (S52) and 4a (ED43). Production of G418-resistant colonies by S52 and ED43 in Huh-7.5 cells required the amino acid substitutions S2210I and R2882G, respectively, cell culture adaptive mutations originally reported for genotype 1b replicons. RNA replication was confirmed by quantitative reverse transcription-PCR and detection of viral protein. Sequencing of multiple independent replicon clones revealed the presence of additional nonsynonymous mutations. Interestingly, all potentially adaptive mutations mapped to the NS3 protein. These mutations, when introduced back into original constructs, substantially increased colony formation efficiency. To make these replicons useful for high-throughput screening and evaluation of antiviral compounds, they were modified to express a chimeric fusion protein of firefly luciferase and neomycin phosphotransferase to yield stable replicon-expressing cells. Using these constructs, the inhibitory effects of beta interferon (IFN-β), an NS3 protease inhibitor, and an NS5B nucleoside polymerase inhibitor were readily detected by monitoring luciferase activity. In conclusion, we have established functional replicons for HCV genotypes 3a and 4a, important new additions to the armamentarium required to develop inhibitors with a pan-genotype activity.
spellingShingle Saeed, M
Scheel, T
Gottwein, J
Marukian, S
Dustin, L
Bukh, J
Rice, C
Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
title Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
title_full Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
title_fullStr Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
title_full_unstemmed Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
title_short Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
title_sort efficient replication of genotype 3a and 4a hepatitis c virus replicons in human hepatoma cells
work_keys_str_mv AT saeedm efficientreplicationofgenotype3aand4ahepatitiscvirusrepliconsinhumanhepatomacells
AT scheelt efficientreplicationofgenotype3aand4ahepatitiscvirusrepliconsinhumanhepatomacells
AT gottweinj efficientreplicationofgenotype3aand4ahepatitiscvirusrepliconsinhumanhepatomacells
AT marukians efficientreplicationofgenotype3aand4ahepatitiscvirusrepliconsinhumanhepatomacells
AT dustinl efficientreplicationofgenotype3aand4ahepatitiscvirusrepliconsinhumanhepatomacells
AT bukhj efficientreplicationofgenotype3aand4ahepatitiscvirusrepliconsinhumanhepatomacells
AT ricec efficientreplicationofgenotype3aand4ahepatitiscvirusrepliconsinhumanhepatomacells